Beryl Drugs Ltd. | Cash Flow
Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
4,314.00
1,697.00
2,708.00
1,701.00
-
Depreciation, Depletion & Amortization
3,200.00
5,161.00
4,101.00
3,776.00
-
Other Funds
3,619.00
3,942.00
4,609.00
3,278.00
-
Funds from Operations
3,895.00
2,916.00
2,200.00
2,199.00
13,226.00
Changes in Working Capital
8,995.00
274.00
5,513.00
1,503.00
-
Net Operating Cash Flow
5,100.00
2,642.00
3,313.00
696.00
-
Capital Expenditures
3,911.00
2,845.00
1,969.00
2,023.00
-
Sale of Fixed Assets & Businesses
-
522.00
-
200.00
-
Purchase/Sale of Investments
5,038.00
2,276.00
18.00
-
-
Net Investing Cash Flow
2,982.00
1,953.00
1,695.00
522.00
-
Issuance/Reduction of Debt, Net
5,206.00
1,662.00
243.00
119.00
-
Net Financing Cash Flow
733.00
1,662.00
243.00
119.00
-
Net Change in Cash
1,385.00
6,257.00
1,861.00
1,337.00
-
Free Cash Flow
9,011.00
137.00
5,282.00
1,327.00
-
Other Sources
1,855.00
2,000.00
3,646.00
2,345.00
-
Change in Capital Stock
4,473.00
-
-
-
-
About Beryl Drugs
View Profile
